The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions - Ivanova, Anastasia; Israel, Elliot; Denlinger, Loren C.; Phipatanakul, Wanda; Bacharier, Leonard B.; Castro, Mario; Gaston, Benjamin; Khatri, Sumita; Kirwan, John P.; Marquis, M. Alison; Moy, James N.; Ortega, Victor E.; et al. (Journal of allergy and clinical immunology, 2022)
Keywords: adaptive clinical trial design; Adaptive Clinical Trials as Topic; Advisory Committees; Asthma - diagnosis; Asthma - drug therapy; asthma exacerbation; biomarker; Biomarkers; Clinical Protocols; Clinical Trials, Phase II as Topic; Humans; non–type 2 asthma; patient advisory committee; Precision Medicine; Research Design; Severe asthma; Severity of Illness Index; Tomography, X-Ray Computed; type 2 asthma; CRP; Feno; NO; FDA; PPC; DSMB; RV; non–type 2 asthma; RTI; DMCC; GSNOR; TLC; patient advisory committee; GSNO; RFA; COVID-19; SC; SNP; MC; asthma exacerbation; Severe asthma; EC; adaptive clinical trial design; CC; ppb; PrecISE; AE; CompEx; Treg; SARP; ACQ-6; biomarker; type 2 asthma; STAT; PAC; TCA; NHLBI; JAK; SAE; ICS; IRB; precision medicine; PI; MCT